Home > > Asia And Global Osteoarthritis Therapeutics Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: ASIA OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. ASIA 3.2.1. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. JAPAN 3.2.4.1.1. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. CHINA 3.2.4.2.1. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.3. INDIA 3.2.4.3.1. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.3.2. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.3.3. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.4. AUSTRALIA 3.2.4.4.1. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.4.2. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.4.3. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.5. ROAPAC 3.2.4.5.1. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.5.2. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.5.3. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 82. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 18. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 20. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 21. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 22. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 23. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 24. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 26. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 27. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 32. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 37. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 47. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 48. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 53. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 58. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 63. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 68. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 69. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 74. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 79. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 82. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: ASIA OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. ASIA 3.2.1. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. JAPAN 3.2.4.1.1. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. CHINA 3.2.4.2.1. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.3. INDIA 3.2.4.3.1. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.3.2. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.3.3. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.4. AUSTRALIA 3.2.4.4.1. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.4.2. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.4.3. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.5. ROAPAC 3.2.4.5.1. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.5.2. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.5.3. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. ASIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. JAPAN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 18. INDIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 20. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 21. AUSTRALIA OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 22. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 23. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 24. ROAPAC OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 26. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 27. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 32. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 37. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 47. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 48. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 51. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 53. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 56. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 58. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 61. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 63. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 66. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 68. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 69. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 71. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 74. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 77. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 79. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 82. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)